Multiple growth factor and neurotrophin receptors and innate immune components

Multiple growth factor and neurotrophin receptors and innate immune components refers to a complex signaling network targeted by multi-functional therapeutic agents, most notably the peptide GM604 (Alirinetide) [1]. This target profile includes the Insulin Receptor (IR), Insulin-like Growth Factor 1 and 2 Receptors (IGF1R, IGF2R), and various neurotrophin receptors like TrkA and TrkB, alongside innate immune elements such as Toll-like receptors (TLRs) [1, 2]. Biologically, these components govern critical pathways for neuronal survival, axonal growth, and the regulation of neuroinflammation [2]. In neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's, these pathways are often dysregulated, leading to protein misfolding and chronic inflammation [3]. Drugs interacting with this broad target set act as master regulators, attempting to restore homeostatic balance by simultaneously promoting neuroprotection and suppressing harmful immune responses [1, 3]. While this multi-target approach aims to address the multifactorial nature of neurodegeneration, it poses significant challenges for traditional drug development models that favor single-target specificity [2, 3].

Other names

Multi-target master regulatorGM604 target complexGrowth factor and neurotrophin signaling networkInsulin receptor/IGF1R/Neurotrophin receptor signaling systemGM6

Simultaneous agonism of growth factor and neurotrophin receptors and modulation of innate immune signaling to restore cellular homeostasis.